Thyroid hormone responsive genes in the murine hepatocyte cell line AML 12

Gene

Volumn 396, Issue 2, 2007, Pages 332-337

  Ventura Holman, Tereza ^b   Mamoon, Abulkhair ^b   Maher, Joseph F ^c   Subauste, Jose S ^a,b  

^a G V SONNY MONTGOMERY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Gene regulation; Hepatocellular carcinoma; Microarrays; Nuclear receptor

Indexed keywords

COMPLEMENTARY DNA; THYROID HORMONE;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE CONTROL; GENE OVEREXPRESSION; HORMONE RESPONSE; LIVER CELL CULTURE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL LINE, TUMOR; CHOLESTEROL; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION; HEPATOCYTES; LIVER NEOPLASMS; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID HORMONES; TRANSFECTION; TRIIODOTHYRONINE;

ANIMALIA; MURINAE;

EID: 34250677676     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2007.04.005     Document Type: Article

References (39)

1. Anderson L.V.B., et al. Dysferlin is a plasma membrane protein and is expressed early in human development. Hum. Mol. Genet. 8 (1999) 855-861
2. Ariel I., et al. Imprinted H19 oncofetal RNA is a candidate tumor marker for hepatocellular carcinoma. J. Clin. Pathol.: Mol. Pathol. 51 (1998) 21-25
3. Barlow C., Meister B., Lardelli M., Lendahl U., and Vennstrom B. Thyroid abnormalities and hepatocellular carcinoma in mice transgenic for v-erbA. EMBO J. 13 (1994) 4241-4250
4. Bartolomei M.S., Zemel S., and Tilghman S.M. Parental imprinting of the mouse H19 gene. Nature 351 (1991) 153-155
5. Bassett J.H., Harvey C.B., and Williams G.R. Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol. Cell. Endocrinol. 213 (2003) 1-11
6. Beckett G.J., and Arthur J.R. Selenium and endocrine systems. J. Endocrinol. 184 (2005) 455-465
7. Belkhou R., Bechet D., Cherel Y., Galluser M., Ferrara M., and le Maho Y. Effect of fasting and thyroidectomy on cysteine proteinase activities in liver and muscle. Biochim. Biophys. Acta 1199 (1994) 195-201
8. Chan I.H., and Privalsky M.L. Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs. Oncogene 25 (2006) 3576-3588
9. Dalla Valle L., Vianello S., Belvedere P., and Colombo L. Rat cytochrome P450c17 gene transcription is initiated at different start sites in extraglandular and glandular tissues. J. Steroid Biochem. Mol. Biol. 82 (2002) 377-384
10. Darnet S., and Rahier A. Plant sterol biosynthesis: identification of two distinct families of sterol 4alpha-methyl oxidases. Biochem. J. 15 (2004) 889-898
11. Feng X., Jiang Y., Meltzer P., and Yen P.M. Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol. Endocrinol. 14 (2000) 947-955
12. Flores-Morales A., Gullberg H., Fernandez L., Stahlberg N., Lee N.H., Vennstrom B., and Norstedt G. Patterns of liver gene expression governed by TRβ. Mol. Endocrinol. 16 (2002) 1257-1268
13. Hegardt F.G. Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis. Biochem. J. 338 (1999) 569-582
14. Iizuka N., et al. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res. 62 (2002) 3939-3944
15. Jeong S.J., et al. Transcriptional abnormality of the hsMAD2 mitotic checkpoint gene is a potential link to hepatocellular carcinoma. Cancer Res. 64 (2004) 8666-8673
16. Kikuchi S., et al. Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes. Nat. Genet. 31 (2002) 320-325
17. Kirchner J., Forbush K.A., and Bevan M.J. Identification and characterization of thymus LIM protein: targeted disruption reduces thymus cellularity. Mol. Cell. Biol. 21 (2001) 8592-8604
18. Laudet V., et al. Genomic organization of the human thyroid hormone receptor a (c-erbA-1) gene. Nucleic Acids Res. 19 (1991) 1105-1112
19. Ledda-Columbano G.M., et al. Different effects of the liver mitogens tri-iodo-thyronine and ciprofibrate on the development of rat hepatocellular carcinoma. Toxicol. Pathol. 31 (2003) 113-120
20. Li X., Gu W., Mohan S., and Baylink D.J. DNA microarrays: their use and misuse. Microcirculation 9 (2002) 13-22
21. Lin K.H., et al. Plasma protein regulation by thyroid hormone. J. Endocrinol. 179 (2003) 367-377
22. Liu Y., Yao Z.X., and Papadopoulos V. Cytochrome P450 17alpha hydroxylase/17,20 lyase (CYP 17) function in cholesterol biosynthesis: identification of squalene monooxygenase (epoxidase) activity associated with CYP17 in Leydig cells. Mol. Endocrinol. 19 (2005) 1918-1931
23. Manna P.R., Kero J., Tena-Sempere M., Pakarinen P., Stocco D.M., and Huhtaniemi I.T. Assessment of mechanisms of thyroid hormone action in mouse Leydig cells: regulation of the steroidogenesis, and luteinizing hormone receptor function. Endocrinology 142 (2001) 319-331
24. Nagaya T., et al. Intracellular proteolytic cleavage of 9-cis-retinoic acid receptor alpha by cathepsin L-type protease is a potential mechanism for modulating thyroid hormone action. J. Biol. Chem. 273 (1998) 33166-33173
25. Romero D.G., Plonczynski M., Vergara G.R., Gomez-Sanchez E.P., and Gomez-Sanchez C.E. Angiotensin II early regulated genes in H295R human adrenocortical cells. Physiol. Genomics 19 (2004) 106-116
26. Royo T., Haro D., and Hegardt F.G. Regulation of cytosolic 3-hydroxy-3-methylglutaryl-CoA synthase mRNA levels by l-tri-iodothyronine. Biochem. J. 289 (1993) 557-560
27. Saumya S.M., Sreejith P., Vijayasree A.S., Divya L., Manju M., and Oommen O.V. Tri-iodo thyronine regulates antioxidant enzyme activities in different cell fractions through a mechanism sensitive to actinomycin D in a teleost, Anabas testudineus (Bloch). Indian J. Exp. Biol. 44 (2006) 640-646
28. Schwartz H.L., Strait K.A., Ling N.C., and Oppenheimer J.H. Quantitation of rat tissue thyroid hormone binding receptor isoforms by immunoprecipitation of nuclear triiodothyronine binding capacity. J. Biol. Chem. 267 (1992) 11794-11799
29. Shen Q., and Subauste J.S. Dimerization interfaces of v-erbA homodimers and heterodimers with RXR alpha. J. Biol. Chem. 275 (2000) 41018-41027
30. Shih C.H., et al. Thyroid hormone receptor-dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology 145 (2004) 2804-2814
31. Stears R.L., Getts R.C., and Gullans S.R. A novel, sensitive detection system for high-density microarrays using dendrimer technology. Physiol. Genomics 3 (2000) 93-99
32. Szydlowska M., Nagel-Starczynowska G., Rybakowska I., Swieca A., and Kaletha K. Human liver AMP-deaminase - oligomeric forms of the enzyme. Mol. Cell. Biochem. 241 (2002) 81-86
33. Tappaz M.L. Taurine biosynthetic enzymes and taurine transporter: Molecular identification and regulations. Neurochem. Res. 29 (2004) 83-96
34. Vernucci M., Cerrato F., Pedone P.V., Dandolo L., Bruni C.B., and Riccio A. Developmentally regulated functions of the H19 differentially methylated domain. Hum. Mol. Genet. 13 (2004) 353-361
35. Vianello S., Waterman M.R., Dalla Valle L., and Colombo L. Developmentally regulated expression and activity of 17alpha-hydroxylase/C-17,20-lyase cytochrome P450 in rat liver. Endocrinology 138 (1997) 3166-3174
36. Xia Y., Sidis Y., and Schneyer A. Overexpression of follistatin-like 3 in gonads causes defects in gonadal development and function in transgenic mice. Mol. Endocrinol. 18 (2004) 979-994
37. Yehuda-Shnaidman E., Kalderon B., and Bar-Tana J. Modulation of mitochondrial transition pore components by thyroid hormone. Endocrinology 146 (2005) 2462-2472
38. Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81 (2001) 1097-1142
39. Zubkova I., and Subauste J.S. Sequences required for the transition from monomeric to homodimeric forms of thyroid hormone receptor alpha and v-erbA. Mol. Cell. Endocrinol. 199 (2003) 61-72